Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-25-044948
Filing Date
2025-05-16
Accepted
2025-05-16 17:15:11
Documents
4
Period of Report
2025-06-13

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT ea0239463-02.htm DEF 14A 249258
2 GRAPHIC tinmed_logo.jpg GRAPHIC 114164
3 GRAPHIC tproxy_001.jpg GRAPHIC 964091
4 GRAPHIC tproxy_002.jpg GRAPHIC 1330664
  Complete submission text file 0001213900-25-044948.txt   3568878
Mailing Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8
Business Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-39685 | Film No.: 25960586
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)